George Chang
Papers
2
Total Citations
39
H-Index
2
About
George Chang is a pioneering medicinal chemist whose work has fundamentally advanced the development of lipid-lowering therapeutics. His primary research focuses on the discovery and optimization of microsomal triglyceride transfer protein (MTP) inhibitors, a critical mechanism for blocking hepatic VLDL and intestinal chylomicron secretion. His landmark 2002 paper, which has garnered 32 citations, details the identification of clinically active MTP inhibitors through innovative high-throughput screening and parallel synthesis paradigms, establishing a highly efficacious pharmacological strategy for reducing low-density lipoproteins. More recently, Chang has pushed the boundaries of drug metabolism research with his 2024 study on multiplexed high-throughput screening of selective inhibitors using human hepatocytes, a work already accumulating 7 citations. This novel approach enables more precise evaluation of drug-metabolizing enzymes, promising safer and more effective therapeutic candidates. Through his dual contributions to both lipid management and advanced screening methodologies, Chang has demonstrated a sustained commitment to translating chemical innovation into tangible clinical solutions, making him a respected figure in pharmaceutical discovery.
Research Focus
Key Achievements
Top Papers
- 1
- 2